Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price increased by research analysts at UBS Group from $38.00 to $39.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s target price indicates a potential upside of 29.96% from the company’s previous close.
A number of other equities research analysts also recently weighed in on KDP. Wells Fargo & Company set a $37.00 price target on Keurig Dr Pepper in a report on Wednesday, July 1st. Barclays upgraded Keurig Dr Pepper from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $30.00 to $36.00 in a research note on Thursday, June 25th. BNP Paribas Exane upgraded shares of Keurig Dr Pepper from an “underperform” rating to a “neutral” rating and set a $28.00 target price for the company in a research note on Wednesday, April 22nd. Citigroup increased their target price on shares of Keurig Dr Pepper from $32.00 to $37.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $42.00 price target on shares of Keurig Dr Pepper in a report on Tuesday. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $34.00.
Read Our Latest Stock Analysis on KDP
Keurig Dr Pepper Stock Down 1.2%
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Keurig Dr Pepper had a return on equity of 10.51% and a net margin of 10.81%.The business had revenue of $7.31 billion during the quarter, compared to the consensus estimate of $7.23 billion. During the same period last year, the firm earned $0.49 earnings per share. The company’s revenue for the quarter was up 75.6% compared to the same quarter last year. Research analysts predict that Keurig Dr Pepper will post 2.29 earnings per share for the current year.
Hedge Funds Weigh In On Keurig Dr Pepper
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in Keurig Dr Pepper by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 160,958,816 shares of the company’s stock valued at $4,508,456,000 after acquiring an additional 1,538,456 shares in the last quarter. BlackRock Inc. bought a new position in shares of Keurig Dr Pepper in the second quarter worth $4,697,645,000. State Street Corp increased its holdings in shares of Keurig Dr Pepper by 1.6% during the third quarter. State Street Corp now owns 64,594,706 shares of the company’s stock valued at $1,662,361,000 after purchasing an additional 986,700 shares during the period. Wellington Management Group LLP increased its holdings in shares of Keurig Dr Pepper by 37.0% during the fourth quarter. Wellington Management Group LLP now owns 57,003,344 shares of the company’s stock valued at $1,596,664,000 after purchasing an additional 15,393,753 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Keurig Dr Pepper by 3.9% during the fourth quarter. Geode Capital Management LLC now owns 31,802,056 shares of the company’s stock valued at $887,021,000 after purchasing an additional 1,187,457 shares in the last quarter. 93.99% of the stock is owned by institutional investors.
More Keurig Dr Pepper News
Here are the key news stories impacting Keurig Dr Pepper this week:
- Positive Sentiment: Q2 results exceeded expectations. KDP reported adjusted earnings of $0.57 per share, above consensus estimates of roughly $0.54-$0.55, while revenue reached $7.31 billion versus expectations of $7.23 billion. EPS increased from $0.49 a year earlier. Keurig Dr Pepper Reports Q2 Results and Reaffirms Guidance for 2026
- Positive Sentiment: Growth benefited from U.S. Refreshment Beverages and JDE Peet’s. Management and analysts pointed to continued momentum in the U.S. beverage business, contributions from the JDE Peet’s acquisition, and efficiency initiatives as key drivers of the quarterly performance. Reported revenue rose 75.6% year over year, although the increase was significantly affected by the acquisition. Keurig Q2 Earnings and Sales Beat Estimates on JDE Peet’s Strength
- Positive Sentiment: RBC Capital maintained a Buy rating. The continued bullish analyst stance provides support for KDP’s investment case following the earnings report. RBC Capital Remains a Buy on Keurig Dr Pepper
- Neutral Sentiment: Full-year guidance was reaffirmed rather than increased. KDP maintained its 2026 constant-currency sales outlook of $25.9 billion to $26.4 billion, broadly in line with the approximately $26.2 billion consensus estimate, and reaffirmed its adjusted EPS outlook. This limits the potential for a major positive earnings-revision catalyst. Keurig Dr Pepper Maintains Annual Forecasts After Quarterly Results Beat
- Negative Sentiment: Investors remain focused on execution risk. The company is continuing work to separate into two businesses and is targeting a pro forma year-end management leverage ratio of 4.1 times. The separation costs, operational complexity and elevated leverage could temper enthusiasm despite the quarterly beat. Keurig Dr Pepper Posts Higher Sales as Separation Work Continues
Keurig Dr Pepper Company Profile
Keurig Dr Pepper (NASDAQ: KDP) is a North American beverage company formed in July 2018 through the combination of Keurig Green Mountain and Dr Pepper Snapple Group. The company designs, manufactures, markets and distributes a wide range of hot and cold beverages and related equipment, combining Keurig’s single‑serve coffee systems with a large portfolio of carbonated and noncarbonated drink brands. It operates a network of manufacturing, packaging and distribution facilities to supply retail, foodservice and e-commerce channels across its served markets.
The company’s product mix includes single‑serve coffee brewers and coffee pods under the Keurig brand as well as a broad assortment of branded beverages.
Recommended Stories
- Five stocks we like better than Keurig Dr Pepper
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.
